ALDX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.44

Margin Of Safety %

Put/Call OI Ratio

0.41

EPS Next Q Diff

-0.04

EPS Last/This Y

0.22

EPS This/Next Y

0.06

Price

0.62

Target Price

6.6

Analyst Recom

1.4

Performance Q

-59.61

Upside

-1,877.8%

Beta

1.28

Ticker: ALDX

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	ALDX	0.7905	0.17	15.63	3973
2026-10-15	ALDX	0.7402	0.42	0.19	4872
2026-10-16	ALDX	0.7	0.42	0.18	4876
2026-10-19	ALDX	0.6651	0.54	0.04	3904
2026-10-20	ALDX	0.7246	0.53	0.60	3988
2026-10-21	ALDX	0.6766	0.53	0.00	3993
2026-10-22	ALDX	0.6373	0.53	4.00	3998
2026-10-23	ALDX	0.6497	0.54	1.28	4036
2026-10-26	ALDX	0.6504	0.57	0.02	3791
2026-10-27	ALDX	0.6303	0.50	0.00	4134
2026-10-28	ALDX	0.69	0.49	6.50	4182
2026-10-29	ALDX	0.6596	0.49	0.26	4192
2026-10-30	ALDX	0.5601	0.48	999.99	4225
2026-11-02	ALDX	0.5921	0.49	999.99	3824
2026-11-03	ALDX	0.6271	0.46	0.06	4003
2026-11-04	ALDX	0.6522	0.45	0.03	4026
2026-11-05	ALDX	0.6178	0.43	0.75	4154
2026-11-06	ALDX	0.6368	0.43	0.00	4164
2026-11-09	ALDX	0.6301	0.42	0.19	4249
2026-11-10	ALDX	0.6273	0.41	0.00	4274
2026-11-11	ALDX	0.6466	0.41	0.09	4275
2026-11-12	ALDX	0.6229	0.41	999.99	4299
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	ALDX	0.79	28.9	-	-0.34
2026-10-15	ALDX	0.74	28.9	-	-0.34
2026-10-16	ALDX	0.70	28.9	-	-0.34
2026-10-19	ALDX	0.67	28.9	-	-0.34
2026-10-20	ALDX	0.67	28.9	-	-0.34
2026-10-21	ALDX	0.73	28.9	-	-0.34
2026-10-22	ALDX	0.64	28.9	-	-0.34
2026-10-23	ALDX	0.65	28.9	-	-0.34
2026-10-26	ALDX	0.65	28.9	-	-0.34
2026-10-27	ALDX	0.64	28.9	-	-0.34
2026-10-28	ALDX	0.69	28.9	-	-0.34
2026-10-29	ALDX	0.66	28.9	-	-0.34
2026-10-30	ALDX	0.56	28.9	-	-0.34
2026-11-02	ALDX	0.58	28.9	-	-0.34
2026-11-03	ALDX	0.63	28.9	-	-0.34
2026-11-04	ALDX	0.65	28.9	-	-0.34
2026-11-05	ALDX	0.62	28.9	-	-0.34
2026-11-06	ALDX	0.64	28.9	-	-0.34
2026-11-09	ALDX	0.63	28.9	-	-0.34
2026-11-10	ALDX	0.62	28.9	-	-0.34
2026-11-11	ALDX	0.65	28.9	-	-0.34
2026-11-12	ALDX	0.62	28.9	-	-0.34
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	ALDX	12.61	-3.95	5.97
2026-10-15	ALDX	12.61	-3.95	5.97
2026-10-16	ALDX	12.61	-3.95	5.97
2026-10-19	ALDX	12.61	-3.94	5.97
2026-10-20	ALDX	12.61	-3.94	5.97
2026-10-21	ALDX	12.61	-3.94	5.97
2026-10-22	ALDX	12.61	-3.94	5.97
2026-10-23	ALDX	12.61	-3.94	5.97
2026-10-26	ALDX	12.61	-4.33	5.97
2026-10-27	ALDX	12.61	-4.33	5.48
2026-10-28	ALDX	12.61	-4.33	5.48
2026-10-29	ALDX	12.61	-4.33	5.48
2026-10-30	ALDX	12.61	-4.33	5.48
2026-11-02	ALDX	12.61	-4.91	5.48
2026-11-03	ALDX	12.61	-4.91	5.48
2026-11-05	ALDX	12.61	-4.91	5.48
2026-11-06	ALDX	12.61	-4.91	5.48
2026-11-09	ALDX	12.61	-5.45	5.48
2026-11-10	ALDX	12.61	-5.45	5.48
2026-11-11	ALDX	12.60	-5.45	5.44
2026-11-12	ALDX	12.61	-5.45	5.44
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.06

Avg. EPS Est. Current Quarter

-0.09

Avg. EPS Est. Next Quarter

-0.1

Insider Transactions

12.61

Institutional Transactions

-5.45

Beta

1.28

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

94.8

Max Drawdown 5-Year %

-95.3

Target Price

6.6

P/E

Forward P/E

PEG

P/S

P/B

1.08

P/Free Cash Flow

EPS

-0.32

Average EPS Est. Cur. Y

-0.34

EPS Next Y. (Est.)

-0.28

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.49

Return on Equity vs Sector %

-80.7

Return on Equity vs Industry %

-61.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ ALDX Healthcare

$0.63

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

10/20

Pullback

18/25

Volume

11/15

Valuation

12/20

TP/AR

2/10

Options

4/10

RSI

36.3

Range 1M

21.7%

Sup Dist

3.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

21/30

Estimates

0/20

Inst/Vol

0/15

Options

3/10

EPS Yr

43.6%

EPS NY

15.8%

52W%

1.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +947.6% upside

Quality

3/30

Valuation

16/30

Growth

16/25

Stability

7/10

LT Trend

1/5

Upside

+947.6%

Quality

ALDX — P/E HistoricalBiotechnology

Aldeyra Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 8

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of primary vitreoretinal lymphoma and retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platforms, including ADX 248, ADX 246, and other novel RASP modulators for the treatment of various diseases associated with RASP. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

ALDX

Latest News

—

Caricamento notizie per ALDX…

stock quote shares ALDX – Aldeyra Therapeutics, Inc. Stock Price stock today

news today ALDX – Aldeyra Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ALDX – Aldeyra Therapeutics, Inc. yahoo finance google finance

stock history ALDX – Aldeyra Therapeutics, Inc. invest stock market

stock prices ALDX premarket after hours

ticker ALDX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ALDX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y